Inflammatory Complications of Intravitreal Anti-VEGF Injections

Inflammatory Complications of Intravitreal Anti-VEGF Injections

Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents is a commonly used therapy for numerous retinal diseases. The most commonly used of these medications are bevacizumab, ranibizumab, aflibercept, and brolucizumab. However, intravitreal administration of these agents...

Full description

Bibliographic Details
Main Authors: Jacob T. Cox, Dean Eliott, Lucia Sobrin
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
anti-vascular endothelial growth factor (anti-VEGF)
intravitreal
intraocular inflammation
brolucizumab
bevacizumab
ranibizumab
Online Access:https://www.mdpi.com/2077-0383/10/5/981

Internet

https://www.mdpi.com/2077-0383/10/5/981

Similar Items